BioLineRx (BLRX) Debt Ratio (2015 - 2025)

BioLineRx's Debt Ratio history runs 11 years deep, the most recent figure standing at 0.22 for Q4 2025.

• In Q4 2025, Debt Ratio fell 36.73% year-over-year to 0.22; the TTM figure through Dec 2025 stood at 0.22 (down 36.73% YoY), while the FY2025 annual figure was 0.22, down 36.73% from the prior year.
• Debt Ratio was 0.22 for Q4 2025 at BioLineRx, down from 0.25 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.53 in Q3 2024 to a low of 0.01 in Q2 2022.
• Historically, Debt Ratio has averaged 0.19 across 5 years, with a median of 0.17 in 2024.
• The sharpest annual moves came in 2021 and 2023: Debt Ratio sank 72.53% in 2021, then jumped 1215.01% in 2023.
• A 5-year view of Debt Ratio shows it stood at 0.03 in 2021, then jumped by 292.98% to 0.13 in 2022, then increased by 14.85% to 0.15 in 2023, then surged by 125.91% to 0.35 in 2024, then sank by 36.73% to 0.22 in 2025.
• The last three Debt Ratio figures came in at 0.22 (Q4 2025), 0.25 (Q3 2025), and 0.26 (Q2 2025), per Business Quant data.